C07K 14/45
Toxoplasma
C07K14/45 (Toxoplasma) appears on 59 US grants and 56 published applications in this corpus.
Search patents in C07K- Granted patents
- 59
- Published applications
- 56
- Assignees
- 58
- Inventors
- 152
- Latest grant
- 25 Mar 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 2 | 0 |
| 1996 | 2 | 0 |
| 1997 | 5 | 0 |
| 1998 | 3 | 0 |
| 1999 | 2 | 0 |
| 2000 | 2 | 0 |
| 2001 | 2 | 1 |
| 2002 | 5 | 2 |
| 2003 | 1 | 2 |
| 2004 | 0 | 1 |
| 2005 | 1 | 2 |
| 2006 | 2 | 2 |
| 2007 | 1 | 1 |
| 2008 | 2 | 4 |
| 2009 | 2 | 6 |
| 2010 | 4 | 2 |
| 2011 | 1 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 2 |
| 2015 | 0 | 1 |
| 2016 | 2 | 1 |
| 2017 | 2 | 1 |
| 2018 | 1 | 2 |
| 2019 | 1 | 1 |
| 2020 | 2 | 3 |
| 2021 | 1 | 5 |
| 2022 | 3 | 6 |
| 2023 | 2 | 3 |
| 2024 | 5 | 3 |
| 2025 | 1 | 3 |
By publication year. Applications have been published since 2001.
Recent patents
- Methods and compositions for assessing antibody specificities25 Mar 2025US 12,259,396 B2Serimmune Inc.
- Immunologically active fragments of toxoplasma gondii3 Dec 2024US 12,156,906 B2Washington University
- Methods and compositions for assessing antibody specificities19 Nov 2024US 12,146,884 B2Serimmune Inc.
- Engineered parasites for delivering protein to the central nervous system (CNS)27 Aug 2024US 12,070,476 B2Ramot at Tel-Aviv University Ltd.
- Compositions and methods for regulation of chronic toxoplasma infection2 Apr 2024US 11,945,845 B2Whitehead Institute for Biomedical Research
- Antigenic regions for the detection of anti-toxoplasma gondii igm antibodies29 May 2025US 2025/0171508 A1Biokit Research & Development S.L.U.
- Treatment and diagnosis of toxoplasma-associated disease27 Feb 2025US 2025/0067735 A1The Johns Hopkins University
- Engineered parasites for delivering protein to the central nervous system (cns)20 Feb 2025US 2025/0057892 A1Ramot at Tel-Aviv University Ltd.
- Methods and compositions for assessing antibody specificities5 Dec 2024US 2024/0402189 A1Serimmune Inc.
- Virus-like particle comprising toxoplasma gondii protein and influenza virus protein, and diagnostic method using same14 Mar 2024US 2024/0085420 A1Health Park Incorporated
Most cited
By later US patents
- Recombinant packaging defective Sindbis virus vaccines59US 5,766,602 AHeska Corporation · 1998
- Vaccines containing non-ionic surfactant vesicles41US 5,679,355 AProteus Molecular Design Limited · 1997
- Diagnostic genes for toxoplasmosis14US 5,629,414 AThe Board of Trustees of the Leeland Stanford Junior University · 1997
- P30 peptides of Toxoplasma gondii13US 5,859,196 AThe Trustees of the Leland Stanford Junior University · 1999
- Mimotopic polypeptides of Toxoplasma gondii and applications9US 5,851,535 ABio Merieux · 1998